Abstract
Holographic optical coherence imaging is an en face form of optical coherence tomography that uses low-coherence digital holography as a coherence gate to select light from a chosen depth inside scattering tissue. By acquiring successive holograms at a high camera frame rate at a fixed depth, dynamic speckle provides information concerning dynamic light scattering from intracellular motility. Motility contrast imaging (MCI) uses living motion as a label-free and functional biomarker. MCI provides a new form of viability assay and also is applicable for proliferation and cytotoxicity assays. The results presented here demonstrate that low-coherence digital holography can extract viability information from biologically relevant three-dimensional (3D) tissue based on multicellular tumor spheroids by moving beyond the format of two-dimensional cell culture used for conventional high-content analysis. This paper also demonstrates the use of MCI for chemosensitivity assays on tumor exgrafts of excised ovarian cancer tumors responding to standard-of-care cisplatin chemotherapy. This ex vivo application extends the applicability of MCI beyond 3D tissue culture grown in vitro.
© 2012 Optical Society of America
Full Article | PDF ArticleMore Like This
Daniel Merrill, Ran An, John Turek, and David D. Nolte
Appl. Opt. 54(1) A89-A97 (2015)
Kwan Jeong, John J. Turek, and David D. Nolte
Opt. Express 15(21) 14057-14064 (2007)
David D. Nolte, Ran An, John Turek, and Kwan Jeong
Biomed. Opt. Express 3(11) 2825-2841 (2012)